Most Active
CD&R and McKesson Agree to Buy Option Care Health for $32.05 a Share in $5.8 Billion Deal
Read this in the Market Flux appOption Care Health, Inc. $OPCH
$31.00+32.65%as of publication
- 5D Change
- +35.67%
- Notional
- $1.99B
Clayton Dubilier & Rice and McKesson have entered into a definitive agreement to acquire Option Care Health for $32.05 per share, placing the total enterprise value of the at-home infusion therapy provider at approximately $5.8 billion. The offer represents a premium of roughly 37% to where the stock had been trading, and sent shares up as much as 33% on the day to around $31.05 on heavy volume.
Under the terms of the deal, CD&R will hold a majority stake of approximately 51% in Option Care Health, while McKesson will retain about 49%. The Financial Times, which first reported the transaction was nearing completion, described the acquisition as the latest buyout of a healthcare services company trading below its historic valuation multiples.
Truist reiterated its Buy rating on Option Care Health ahead of the announcement, and Citizens also maintained its rating as sale talks became public. The deal was widely flagged by analysts as a logical strategic move, with McKesson expanding its footprint in the medical infusion services space through a partnership with one of the largest private equity firms in healthcare.
© AI-generated summary is provided by Market Flux
Sources
- InvestingCitizens maintains Option Care Health stock rating on potential acquisition talks
- CnbcStocks making the biggest moves premarket: Constellation Energy, Option Care Health, Lennar, P&G and more
- Zerohedge*CD&R, MCKESSON TO BUY OPTION CARE HEALTH FOR $32.05/SHR
- BriefingcomGapping up: $OPCH +20.5% $APOG +19.6% $CEG +7.9% $EMAT +5.5% $FRSH +4.7% Gapping down: $TRMD -2.4% $SYRE -2.1% $UMC -1.6% $PCVX -1.4%
- OpenOutcrier$OPCH (+20.5% pre) Option Care Health Inc OPCH shares jumped 22% following reports that McKesson $MCK and Clayton, Dubilier & Rice are close to finalizing a transaction to acquire the home infusion therapy provider for over $5 billion, including debt.
- NasdaqCD&R And McKesson To Acquire Option Care Health
- WsjCD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion
- Financial TimesMcKesson and CD&R strike $5.8bn deal to buy infusion services provider
Show 5 more
- TheflynewsVideo: Constellation Energy up after striking power deal with Google $CEG $GOOGL $CTVA $VYLR $OPCH $MCK $PG $QGEN $FTRE
- BusinessMcKesson and the private equity firm Clayton Dubilier & Rice will buy Option Care Health for an enterprise value of about $5.8 billion, expanding into the medical infusion space
- MarketRebelsSTARTS NOW Rebel's Edge 🏴☠️ 1pm Line up: #VIX $CEG $SPCX $NVDA $OPCH 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian Bijan Robinson, MLB Playoffs #ITSNOTANOPTION 📙
- Proactive_XMarket movers: Constellation Energy, Marvell, Lamb Weston, Option Care Health...
- _Morkie🚨 TOP MOVERS: ArriVent BioPharma plunges -51.90% to $13.69 and Armada Acquisition drops -50.84% to $19.00 in a severe small-cap selloff, while Option Care Health jumps +32.86% to $31.05 on heavy volume.